Evidence map›Paper›PMID 33097726›Full record

ArticleNature communications2020

Genome-scale metabolic rewiring improves titers rates and yields of the non-native product indigoidine at scale.

Deepanwita Banerjee, Thomas Eng, Andrew K Lau, Yusuke Sasaki, Brenda Wang, Yan Chen, Jan-Philip Prahl, Vasanth R Singan, Robin A Herbert, Yuzhong Liu and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Article
  3. A Novel Indigoidine-like NRPS Gene fromAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Computational and structural biotechnology journal · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Balancing Cell Growth and Product Synthesis for Efficient Microbial Cell Factories.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Mitigating genetic instability caused by the excision activity of theApplied and environmental microbiology · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Deepanwita BanerjeeJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.ORCID 0000-0002-0083-0608
Thomas EngJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.ORCID 0000-0002-4974-3863
Andrew K LauJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.
Yusuke SasakiJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.
Brenda WangJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.
Yan ChenJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.
Jan-Philip PrahlBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.
Vasanth R SinganBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.ORCID 0000-0002-9983-5707
Robin A HerbertJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.ORCID 0000-0002-9174-1562
Yuzhong LiuJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.ORCID 0000-0001-5614-1951
Deepti TanjoreBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.
Christopher J PetzoldJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.ORCID 0000-0002-8270-5228
Jay D KeaslingJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA.ORCID 0000-0003-4170-6088
Aindrila MukhopadhyayJoint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville, CA, 94608, USA. amukhopadhyay@lbl.gov.ORCID 0000-0002-6513-7425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High titer, rate, yield (TRY), and scalability are challenging metrics to achieve due to trade-offs between carbon use for growth and production. To achieve these metrics, we take the minimal cut set (MCS) approach that predicts metabolic reactions for elimination to couple metabolite production strongly with growth. We compute MCS solution-sets for a non-native product indigoidine, a sustainable pigment, in Pseudomonas putida KT2440, an emerging industrial microbe. From the 63 solution-sets, our omics guided process identifies one experimentally feasible solution requiring 14 simultaneous reaction interventions. We implement a total of 14 genes knockdowns using multiplex-CRISPRi. MCS-based solution shifts production from stationary to exponential phase. We achieve 25.6 g/L, 0.22 g/l/h, and ~50% maximum theoretical yield (0.33 g indigoidine/g glucose). These phenotypes are maintained from batch to fed-batch mode, and across scales (100-ml shake flasks, 250-ml ambr®, and 2-L bioreactors).

Indexed as

Batch Cell Culture TechniquesBiomassBioreactorsCarbonCulture MediaFermentationGene Knockout TechniquesGenetic EngineeringGenome, BacterialGlucoseIndustrial MicrobiologyPiperidonesPseudomonas putidaSynthetic BiologyCarbonCulture MediaGlucoseindigoidinePiperidones

Identifiers

PMID33097726
PMCPMC7584609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.